| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/17/2006 | WO2006086498A2 Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors |
| 08/17/2006 | WO2006086229A1 The use of selective p2x7 receptor antagonists |
| 08/17/2006 | WO2006085655A1 Ointment |
| 08/17/2006 | WO2006084975A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists |
| 08/17/2006 | WO2006084917A1 Non steroidal glucocorticoid receptor modulators |
| 08/17/2006 | WO2006084338A1 Novel tubulin polymerisation inhibitors |
| 08/17/2006 | WO2006084334A1 Analgesic and anti-inflammatory composition |
| 08/17/2006 | WO2006071601A3 Therapeutic compositions for intranasal administration of ketorolac |
| 08/17/2006 | WO2006067311A3 Cdc25 phosphatase inhibitors |
| 08/17/2006 | WO2006066950A3 Tricyclic aminoalcohols, methods for producing the same and their use as anti-inflammatory agents |
| 08/17/2006 | WO2006060110A3 Process for preparing {3-[2(r)-[(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid |
| 08/17/2006 | WO2006055734A3 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/17/2006 | WO2006054921A3 Anti-inflammatory extract and agent and method for the production thereof |
| 08/17/2006 | WO2006031782A3 Salvinorin derivatives as opioid receptor ligands |
| 08/17/2006 | WO2005117895A3 Compositions comprising meloxicam |
| 08/17/2006 | WO2005102389A3 Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists |
| 08/17/2006 | US20060183921 Pharmaceutically active compounds and methods of use |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183797 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 08/17/2006 | US20060183782 3-[5-(4-methylbenzylidene)-4-oxo-2-thioxothiazolidin-3-yl]-N-(4-sulfamoylphenyl)-propionamide; compounds are protein tyrosine phosphatse inhibitors; antiinflmmatory, anticarcinogenic agents |
| 08/17/2006 | US20060183775 Using N((1-(2-(4-hydroxyphenyl)ethyl)-4-piperidinyl)methyl)-1-isopropyl-1H-indazole-3-carboxamide hydrochloride to treat neuropathic pain caused by trauma, multiple sclerosis, immunodeficiency; ischemia, diabetes and neuralgia |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 08/17/2006 | US20060183739 Carbonyl compounds |
| 08/17/2006 | US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 08/17/2006 | US20060183731 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/17/2006 | US20060183664 Pharmaceutical composition for delayed hypersensitivity |
| 08/17/2006 | US20060183192 Modulation of sodium channels in dorsal root ganglia |
| 08/17/2006 | US20060182809 System for transporting active substances in a biological system |
| 08/17/2006 | US20060182801 Sequestered antagonist formulations |
| 08/17/2006 | CA2597748A1 Non steroidal glucocorticoid receptor modulators |
| 08/17/2006 | CA2597537A1 Ointment |
| 08/17/2006 | CA2597447A1 Novel tubulin polymerisation inhibitors |
| 08/17/2006 | CA2597431A1 A method of producing an analgesic composition from plasma or serum and use in treating pain |
| 08/17/2006 | CA2596613A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists |
| 08/16/2006 | EP1690864A2 Tricyclic purine compounds and their analogs as inhibitors of cytokine signalling |
| 08/16/2006 | EP1690857A1 Modified-protein formation inhibitor |
| 08/16/2006 | EP1690854A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 08/16/2006 | EP1690852A1 Novel target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto |
| 08/16/2006 | EP1690539A2 Salts of tiotropium for treating inflammatory disorders |
| 08/16/2006 | EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 08/16/2006 | EP1690537A1 Derivatives of aryl(or heteroaryl) azolycarbinols for the treatment of fibromyalgia |
| 08/16/2006 | EP1689730A1 Gsk-3 inhibitors isolated from marine organisms |
| 08/16/2006 | EP1689715A1 Tubulin inhibitors |
| 08/16/2006 | EP1689413A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids |
| 08/16/2006 | EP1689408A1 Treatment of inflammatory disorders of the epithelium with low dose 2,3-benzodiazepines |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1509241B1 Novel uses of cephaibols |
| 08/16/2006 | EP1399476B1 Use of soluble cytokeratine-1-fragments in diagnostics |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1272225B1 Lipid-based systems for targeting diagnostic agents |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1252160B1 Methanocarba cycloalkyl nucleoside analogues |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1117682B1 Chi-Conotoxin Peptides as INhibitors of Neuronal Amine Transporters |
| 08/16/2006 | EP0980362B1 Substituted heterocycles and their use in medicaments |
| 08/16/2006 | EP0964677B1 Sustained analgesia achieved with transdermal delivery of buprenorphine |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
| 08/16/2006 | CN1817908A Recombinant solvent protein derivative, its production and use |
| 08/16/2006 | CN1817907A Recombinant solvent protein, its production and use |
| 08/16/2006 | CN1817898A Use of anti-inflammatory medicine for scheelite total saponin and its saponin compound |
| 08/16/2006 | CN1817883A New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 08/16/2006 | CN1817873A Flavane compound and use thereof |
| 08/16/2006 | CN1817865A Preparation of sinomontanine and its hydrobromide |
| 08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
| 08/16/2006 | CN1817366A Medicinal composition for treating rheumatosis and preparation thereof |
| 08/16/2006 | CN1817357A Medicine for treating senile inflammation and autoimmune inflammation by extraction from Chinese herb |
| 08/16/2006 | CN1817343A Anemonin gel |
| 08/16/2006 | CN1269836C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269805C 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269788C Bicyclic aromatic compound and its application in human medicines or animal medicines and cosmetics teconology |
| 08/16/2006 | CN1269504C Medicine for treating rheumatic and rheumatoid arthritis |
| 08/16/2006 | CN1269500C Chinese traditional medicine for treating arthralgia due to wind-dampness and preparation method thereof |
| 08/16/2006 | CN1269498C Quality control method of Chinese medicinal composition possessing antipyretic |
| 08/16/2006 | CN1269494C Medicine for treating numbness and preparing method thereof |
| 08/16/2006 | CN1269491C Isatis root extract composition, its preparation method and application |
| 08/16/2006 | CN1269488C Pharmaceutical composition capable of resisting cancer and easing pain |
| 08/16/2006 | CN1269477C Inflammation-inhibiting compounds |
| 08/16/2006 | CN1269420C Use of nutritional compositions which contain non-digestible polysaccharides |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091353 Isoindole-imide compounds, compositions, and uses thereof |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091316 Protein induced by homogeneous blood transfusion and DNA encoding the same |
| 08/15/2006 | US7091310 Chemokine analogs for the treatment of human disease |
| 08/15/2006 | US7091242 Beta-amino acid derivatives as integrin receptor antagonists |
| 08/15/2006 | US7091237 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091225 Substituted oxazoles and thiazoles as hPPAR alpha agonists |
| 08/15/2006 | US7091224 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |